BGBaris Gulcu

Baris Gulcu

*This is an algorithmically generated author record based on publicly available information.

Baris Gulcu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cross-cultural validation and reliability of the Turkish version of the anal fistula quality of life scale for cryptoglandular anal fistula

    by E. Ergüder, S. Leventoğlu, A. Rencüzoğulları, B. Gülcü, B. Menteş, C. Akyol, Ç. E. Şahin, E. Öztürk, H. Pelgur, İ. Aydın, et al.

    Aim: The aim of this study was to adapt and validate the Cryptoglandular Anal Fistula Quality of Life (AF-QoL) scale for Turkish-speaking patients, providing a disease-specific, patient-reported outcome measure (PROM) to assess quality of life (QoL) in cryptoglandular anal fistula. Methods: A prospective, multicenter, cross-sectional study was conducted across seven tertiary centers in Türkiye. The 22-item AF-QoL scale, originally validated in English, was translated and culturally adapted into Turkish following Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines, including expert consensus and a pilot study ( n = 10). A total of 220 Turkish-speaking adults with cryptoglandular anal fistula completed the scale. Structural validity was evaluated using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). Internal consistency was assessed using Cronbach’s alpha, and item–total correlations. Test–retest reliability was evaluated in a clinically stable subgroup of patients. Results: EFA confirmed a six-domain structure, comprising psychological impact, everyday activities, unpredictability/disease control, seton-related issues, social limitations, and discharge/discomfort, explaining 69.2% of the total variance. CFA demonstrated an acceptable overall model fit ( χ 2 / df = 1.94, root mean square error of approximation [RMSEA] = 0.048, Comparative Fit Index [CFI] = 0.945, standardized root mean square residual [SRMR] = 0.035). The Turkish AF-QoL demonstrated high internal consistency (Cronbach’s α = 0.828), satisfactory item–total correlations ( r = 0.32–0.76), and good test–retest reliability (intraclass correlation coefficient = 0.74), indicating temporal stability. Conclusions: The Turkish version of the AF-QoL demonstrates satisfactory reliability and structural validity for use in Turkish patients with cryptoglandular anal fistula. This cross-cultural validation provides a disease-specific PROM suitable for clinical and research applications. Further studies assessing additional measurement properties, including structural validity, measurement error, and responsiveness, are warranted. Clinical trial registration: This study was not a clinical trial and thus was not registered in a clinical trial registry.


  • Postisometric relaxation technique versus pelvic floor relaxation exercise in the treatment of women with dyssynergic defecation: a controlled trial

    by Nuriye Büyüktaş, Barış Gülcü, Yeşim Bakar, Melih Zeren

    This study aimed to investigate the effects of post-isometric relaxation (PIR) technique and Pelvic floor relaxation exercises (PFRE) on disease symptoms and compare the methods. 42 females with DD were assigned to the PIR (n = 21) or the PFRE group (n = 21), each receiving 8 sessions treatment. Constipation severity (Constipation Severity Instrument-CSI), pain intensity during and after defecation (Visual Analog Scale-VAS), defecation duration, quality of life (Constipation Quality of Life Questionnaire-PAC-QOL), pelvic floor muscle function (Electromyography-EMG), sexual function (Female Sexual Function Index-FSFI) and the impact of DD on pelvic floor functions (Pelvic Floor Impact Questionnaire-short form-PFIQ-7) were assessed at baseline, and at the end of weeks 2 and 4. Defecation duration, pain intensity during and after defecation, CSI and PAC-QOL scores and pelvic floor relaxation activity (p < 0.001) decreased in both groups, with decrease greater in the PIR group (p < 0.001). Pelvic floor muscle contraction activity increased in the PFRE group (p = 0.011), but no difference was found in the second and fourth weeks between the groups (p > 0.005). No significant change was found in the satisfaction score in the PIR group and in sexual desire, sexual arousal, lubrication and satisfaction scores in the PFRE group (p > 0.005). FSFI total (p = 0.001), sexual desire (p = 0.005), sexual arousal (p = 0.004), lubrication (p = 0.012), orgasm (p = 0.020), satisfaction (p = 0.042), and pain (p = 0.001) scores increased more in the PIR group than the PFRE group. PFIQ-7 summary (p < 0.001), Colorectal-Anal Impact Questionnaire (p < 0.001) and Pelvic Organ Prolapse Impact Questionnaire (p = 0.002) scores decreased more in the PIR group. PIR and PFRE may be effective in managing symptoms and improving quality of life in women with DD, with PIR showing potentially greater benefits.

  • Minimally Invasive Pilonidal Sinus Treatment: EPSIT Versus PEBAI Method

    by Baris Gulcu, Ersin Ozturk

    Purpose: We aimed to compare endoscopic pilonidal sinus treatment (EPSIT) and pit/sinus punch needle excision, brushing, ablation and irrigation (PEBAI) method that was performed with principles similar to EPSIT but without fistuloscope and vision in the treatment of pilonidal sinus disease (PSD). Methods: Patients who underwent EPSIT and PEBAI methods for PSD in a single center between January 2020 and October 2021 were retrospectively analyzed. The primary endpoint was healing, the secondary endpoints were operative time, pain, wound closure, quality of life, cosmetic results, and cost. Results: One hundred 4 patients who underwent EPSIT and 184 patients who underwent PEBAI were included in the study. Age (P=0.871), sex (P=0.669), BMI (P=0.176), number of pits (P=0.99) were similar in both groups. The operative time for PEBAI [20 min (18 to 32)] was shorter than EPSIT [32 min (24 to 44)] (PP=0.147) and 14th day(P=0.382) pain scores, postoperative analgesic requirements (P=0.609), time to return to daily activities (P=0.747), time to return to work (P=0.345), and wound complications (P=0.816) were similar, whereas the wound closure time was earlier after EPSIT [32 d (24 to 41)] than after PEBAI [37 d (26 to 58)] (PP=0.382), recurrence rate (P=0.533), quality of life at first month and (Wound evaluation scale score at first year (P=0.252) were similar in both groups. However, the cost of PEBAI [54.8 € (50.13 to 64.96)] was significantly lower than cost of EPSIT [147.36 € (132.53 to 169.60)] (P<0.00001, u value=0, z-score=7.210). Conclusions: PEBAI method is a cheaper alternative to EPSIT with similar surgical principles and clinical outcomes.


  • Open Access

    Ten-Year Recurrence Outcomes in Early Stage and Early Onset Colon Cancer and the Expression Profiles of MicroRNAs and Cancer Stem Cell Markers in These Tumors

    by Secil Ak Aksoy, Berrin Tunca, Tuncay Yilmazlar, Özgen Işik, Ersin Öztürk, Melis Mutlu, Çağla Teki̇n, Baris Gulcu, Nesrin Ugras, Ömer Yerci̇, et al.

    Objective: We hypothesized that microRNAs (miRNAs) might be involved in tumor development by critically regulating cancer stem cell (CSC) markers in the early stages of colon cancer (eCC). This study aimed to determine the expression profiles of miRNAs in CSC-positive eCC patients and examine their associations with recurrence. Materials and Methods: We analyzed CD133, LGR5 and SOX2 expression profiles to determine CSC status in 30 eCC specimens. Then, using the results of RT2 miRNA PCR custom arrays, we evaluated the expression profiles of 38 miRNAs in CSC-positive eCC patients. Results: Recurrence occurred in 5 patients within ten years after surgery. We determined down-regulation of miR-125b and up-regulation of miR-135b were significant in CSC-positive eCC patients (p=0.021, p=0.001, respectively). We found that low expression of miR-125b was associated with recurrence in eCC (p=0.0022). Conclusions: We suggest that recurrence might be prevented by increasing the expression of miR-125b in eCC.

  • Endoscopic pilonidal sinus treatment vs. laser-assisted endoscopic pilonidal sinus treatment: short-term results from a retrospective case-matched study

    by Baris Gulcu, Ersin Ozturk

    Background The aim of this study was to investigate whether the addition of laser to the endoscopic pilonidal sinus treatment (EPSIT), laser-assisted EPSIT (LEPSIT) has an effect on the method and clinical results in the treatment of pilonidal sinus disease (PSD). Methods Between September 2019 and September 2020, patients who underwent LEPSIT and EPSIT procedures for PSD at Bursa Medicana Hospital, Turkey, were matched for age, pit location and number, body mass index (BMI), and sex. The primary endpoint was complete wound healing and the secondary endpoints were quality of life, cosmetic results, and cost. Results Twenty-four LEPSIT patients were matched to 72 EPSIT patients. Eighty-one (84.4%) of the included patients were male, and the median age was 26 years (range 16–52 years). The median follow-up time was 9 months (range 3–15 months).Wound healing rates (LEPSIT; 95.8% vs. EPSIT; 93%; p = 0.99) were similar in both groups. In patients who underwent LEPSIT, the operative time (p = 0.00086) was significantly shorter, time taken to return to work (p = 0.03572) and wound closure (p < 0.00001) were significantly less. However, the time taken to return to daily activities and the percentage of wound complications were similar in both groups. The pain scores on postoperative -days 1 7, and 14 were significantly higher after EPSIT (p = 0.0083, p = 0.00054, and p = 0.0479, respectively). The postoperative analgesic requirement was significantly higher after EPSIT (p = 0.01492). The total hospital cost was significantly less in patients who underwent EPSIT (p < 0.00001). Significantly better cosmetic improvement was observed in LEPSIT procedure (p = 0.00694). First month quality of life (evaluated with the Short Form 36 Health Survey Questionnaire) was similar except for bodily pain (better after LEPSIT). Conclusions The success rates of LEPSIT and EPSIT are similar. LEPSIT results in better wound healing and patient comfort, and a shorter time to return to work.


  • Botulinum toxin injection is an effective alternative for the treatment of chronic anal fissure

    by Baris Gulcu, Ersin Ozturk

    Objectives There are few published data on the optimized use of botulinum toxin A (BTA) for the treatment of chronic anal fissure (CAF). The aim of this study was to investigate the effect of injection of 100 IU BTA into the internal anal sphincter (IAS) at the side opposite of the fissure, using an anal retractor, sedation, and perianal transcutaneous pudendal nerve block. Methods The prospectively maintained data of 132 patients who underwent BTA injection for CAF were retrospectively analyzed. Demographic data, symptom duration, fissure location, post-procedure pain, complications, continence status, response to treatment, and follow-up period were investigated. Postoperative analgesic requirements of patients who did and did not receive pudendal nerve block were compared. Results Eighty-two patients were male and the median age was 40 (18-74) years. Sixty-six patients required no, 46 required oral, and 20 required parenteral analgesics. No complications were observed. Complete response was observed in 105 patients (79.5%). Symptomatic improvement was observed in 67.4% of patients within 3-7 d. Median follow-up was 24 (18-42) months. The median Wexner's incontinence score was 0 (0-8) at 1 month. In all, 104 patients had no, 22 patients had minor, and 6 patients had non-minor incontinence. All patients with incontinence recovered fully within 4 (2-13) weeks. Conclusions BTA injection using an anal retractor under sedation and perianal transcutaneous pudendal nerve block is an effective and safe alternative to partial lateral internal sphincterotomy (LIS) for the treatment of CAF.


  • Endoscopic Pilonidal Sinus Treatment: Rapid Recovery, Satisfactory Success, and High Quality of Life

    by Baris Gulcu, Ersin Ozturk

    Purpose: In the treatment of pilonidal sinus disease (PD), endoscopic pilonidal sinus treatment (EPSIT), a skin-sparing minimally invasive technique, has attracted attention as an effective treatment. The aim of this study to evaluate the treatment success, cosmetic outcomes, and the quality of life in the patients who underwent an EPSIT for PD. Materials and Methods: The prospectively maintained data of 86 patients who underwent EPSIT for PD were retrospectively analyzed. The primary end-point of this study was complete wound healing, while the secondary end-points were the quality of life and cosmetic outcomes. Results: Seventy-two (83.7%) patients were male, and the median age was 28 (16 to 52). The median operative time was 32 (24 to 44) minutes, the median time to return to daily activities was 1 (1 to 4) day, and the median time to return to work was 3 (1 to 11) days. Fifty-two patients (60.4%) required no analgesics. No wound complication was observed. The median follow-up period was 12 (3 to 23) months. The complete wound healing rate was 94.2%, incomplete wound healing rate was 4.6% and the recurrence rate was 1.2%. Treatment failure was observed in 5 of the 6 patients with >3 pits located in the midline. The first-year median Wound evaluation scale score was 0 (0 to 4). The quality of life [physical function, physical role difficulty, pain, general health perception, energy/vitality, social functioning, emotional role, and mental health (P<0.0001)] significantly increased from preoperative levels a month after the EPSIT procedure. Conclusion: EPSIT, a minimally invasive treatment modality for the treatment of sacrococcygeal PD, is an effective treatment that does not hamper the daily life of the patients, presents high success rates, and has satisfactory cosmetic outcomes.